Prognostic impact of membranous ATP-binding cassette Sub-family G member 2 expression in patients with colorectal carcinoma after surgical resection

References

• Higgins CF. ABC transporters: from microorganisms to man. Ann Rev Cell Biol 1992; 8:67-113; PMID:1282354; http://dx.doi.org/10.1146/annurev.cb.08.110192.000435
   PubMedGoogle Scholar
• Kage K, Tsukahara S, Sugiyama T, Asada S, Ishikawa E, Tsuruo T, Sugimoto Y. Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int J Cancer J Int du Cancer 2002; 97:626-30; PMID:11807788; http://dx.doi.org/10.1002/ijc.10100
   PubMed Web of Science ®Google Scholar
• Xu J, Peng H, Chen Q, Liu Y, Dong Z, Zhang JT. Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity. Cancer Res 2007; 67:4373-81; PMID:17483351; http://dx.doi.org/10.1158/0008-5472.CAN-06-3169
   PubMed Web of Science ®Google Scholar
• Doyle L, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003; 22:7340-58; PMID:14576842; http://dx.doi.org/10.1038/sj.onc.1206938
   PubMed Web of Science ®Google Scholar
• Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 1998; 95:15665-70; PMID:9861027; http://dx.doi.org/10.1073/pnas.95.26.15665
   PubMed Web of Science ®Google Scholar
• Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2:48-58; PMID:11902585; http://dx.doi.org/10.1038/nrc706
   PubMed Web of Science ®Google Scholar
• van Herwaarden AE, Schinkel AH. The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins. Trends Pharmacol Sci 2006; 27:10-6; PMID:16337280; http://dx.doi.org/10.1016/j.tips.2005.11.007
   PubMed Web of Science ®Google Scholar
• Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, Schellens JH. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 2001; 61:3458-64; PMID:11309308
   PubMed Web of Science ®Google Scholar
• Schnepf R, Zolk O. Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications. Exp Opin Drug Metab Toxicol 2013; 9:287-306; PMID:23289909; http://dx.doi.org/10.1517/17425255.2013.742063
   PubMed Web of Science ®Google Scholar
• Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001; 7:1028-34; PMID:11533706; http://dx.doi.org/10.1038/nm0901-1028
   PubMed Web of Science ®Google Scholar
• Gutmann H, Hruz P, Zimmermann C, Beglinger C, Drewe J. Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract. Biochem Pharmacol 2005; 70:695-9; PMID:15998509; http://dx.doi.org/10.1016/j.bcp.2005.05.031
   PubMed Web of Science ®Google Scholar
• An Y, Ongkeko WM. ABCG2: the key to chemoresistance in cancer stem cells? Exp Opin Drug Metab Toxicol 2009; 5:1529-42; PMID:19708828; http://dx.doi.org/10.1517/17425250903228834
   PubMed Web of Science ®Google Scholar
• Mo W, Zhang JT. Human ABCG2: structure, function, and its role in multidrug resistance. Int J Biochem Mol Biol 2012; 3:1-27; PMID:22509477
   PubMedGoogle Scholar
• Candeil L, Gourdier I, Peyron D, Vezzio N, Copois V, Bibeau F, Orsetti B, Scheffer GL, Ychou M, Khan QA, et al. ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases. Int J Cancer J Int du Cancer 2004; 109:848-54; PMID:15027118; http://dx.doi.org/10.1002/ijc.20032
   PubMed Web of Science ®Google Scholar
• Mazard T, Causse A, Simony J, Leconet W, Vezzio-Vie N, Torro A, Jarlier M, Evrard A, Del Rio M, Assenat E, et al. Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pump. Mol Cancer Ther 2013; 12:2121-34; PMID:23960095; http://dx.doi.org/10.1158/1535-7163.MCT-12-0966
   PubMed Web of Science ®Google Scholar
• Liu L, Zuo LF, Guo JW. ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance. Mol Med Rep 2014; 9:1299-304; PMID:24535197
   PubMed Web of Science ®Google Scholar
• Huang WC, Hsieh YL, Hung CM, Chien PH, Chien YF, Chen LC, Tu CY, Chen CH, Hsu SC, Lin YM, et al. BCRP/ABCG2 inhibition sensitizes hepatocellular carcinoma cells to sorafenib. PloS One 2013; 8:e83627; PMID:24391798; http://dx.doi.org/10.1371/journal.pone.0083627
   PubMed Web of Science ®Google Scholar
• Suvannasankha A, Minderman H, O'Loughlin KL, Nakanishi T, Ford LA, Greco WR, Wetzler M, Ross DD, Baer MR. Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survival. Br J Haematol 2004; 127:392-8; PMID:15521915; http://dx.doi.org/10.1111/j.1365-2141.2004.05211.x
   PubMed Web of Science ®Google Scholar
• Benderra Z, Faussat AM, Sayada L, Perrot JY, Chaoui D, Marie JP, Legrand O. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias. Clin Cancer Res 2004; 10:7896-902; PMID:15585622; http://dx.doi.org/10.1158/1078-0432.CCR-04-0795
   PubMed Web of Science ®Google Scholar
• Uggla B, Stahl E, Wagsater D, Paul C, Karlsson MG, Sirsjo A, Tidefelt U. BCRP mRNA expression v. clinical outcome in 40 adult AML patients. Leukemia Res 2005; 29:141-6; PMID:15607361; http://dx.doi.org/10.1016/j.leukres.2004.06.004
   PubMed Web of Science ®Google Scholar
• Kim YH, Ishii G, Goto K, Ota S, Kubota K, Murata Y, Mishima M, Saijo N, Nishiwaki Y, Ochiai A. Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer. Lung Cancer 2009; 65:105-11; PMID:19036469; http://dx.doi.org/10.1016/j.lungcan.2008.10.008
   PubMed Web of Science ®Google Scholar
• Yoh K, Ishii G, Yokose T, Minegishi Y, Tsuta K, Goto K, Nishiwaki Y, Kodama T, Suga M, Ochiai A. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Clin Cancer Res 2004; 10:1691-7; PMID:15014021; http://dx.doi.org/10.1158/1078-0432.CCR-0937-3
   PubMed Web of Science ®Google Scholar
• Zhang Q, Li K, Xu JH, Zhao CG, Gao Q, Wu B, Liu XY. Role of ABCG2 expression driven by cisplatin in platinum-containing chemotherapy for gastric cancer. World J Gastroenterol 2013; 19:6630-6; PMID:24151392; http://dx.doi.org/10.3748/wjg.v19.i39.6630
   PubMed Web of Science ®Google Scholar
• Bunting KD. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 2002; 20:11-20; PMID:11796918; http://dx.doi.org/10.1002/stem.200011
   PubMed Web of Science ®Google Scholar
• Jonker JW, Buitelaar M, Wagenaar E, Van Der Valk MA, Scheffer GL, Scheper RJ, Plosch T, Kuipers F, Elferink RP, Rosing H, et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci U S A 2002; 99:15649-54; PMID:12429862; http://dx.doi.org/10.1073/pnas.202607599
   PubMed Web of Science ®Google Scholar
• Giampieri R, Scartozzi M, Loretelli C, Piva F, Mandolesi A, Lezoche G, Del Prete M, Bittoni A, Faloppi L, Bianconi M, et al. Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients. PloS one 2013; 8:e72843; PMID:24023782; http://dx.doi.org/10.1371/journal.pone.0072843
   PubMedGoogle Scholar
• Glasgow SC, Yu J, Carvalho LP, Shannon WD, Fleshman JW, McLeod HL. Unfavourable expression of pharmacologic markers in mucinous colorectal cancer. Br J Cancer 2005; 92:259-64; PMID:15655543
   PubMed Web of Science ®Google Scholar
• Gupta N, Martin PM, Miyauchi S, Ananth S, Herdman AV, Martindale RG, Podolsky R, Ganapathy V. Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer. Biochem Biophy Res Commun 2006; 343:571-7; PMID:16554028; http://dx.doi.org/10.1016/j.bbrc.2006.02.172
   PubMed Web of Science ®Google Scholar
• Liu HG, Pan YF, You J, Wang OC, Huang KT, Zhang XH. Expression of ABCG2 and its significance in colorectal cancer. Asian Pac J Cancer Prev 2010; 11:845-8; PMID:21133588
   PubMed Web of Science ®Google Scholar
• Wang X, Xia B, Liang Y, Peng L, Wang Z, Zhuo J, Wang W, Jiang B. Membranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survival. Cancer Biomark 2013; 13:81-8; PMID:23838136
   PubMed Web of Science ®Google Scholar
• Andersen V, Vogel LK, Kopp TI, Saebo M, Nonboe AW, Hamfjord J, Kure EH, Vogel U. High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence. PloS One 2015; 10:e0119255; PMID:25793771; http://dx.doi.org/10.1371/journal.pone.0119255
   PubMed Web of Science ®Google Scholar
• Larbcharoensub N, Sornmayura P, Sirachainan E, Wilasrusmee C, Wanmoung H, Janvilisri T. Prognostic value of ABCG2 in moderately and poorly differentiated intrahepatic cholangiocarcinoma. Histopathology 2011; 59:235-46; PMID:21884202
   PubMed Web of Science ®Google Scholar
• Silvestris N, Simone G, Partipilo G, Scarpi E, Lorusso V, Brunetti AE, Maiello E, Paradiso A, Mangia A. CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen. Int J Mol Sci 2014; 15:15767-77; PMID:25198900; http://dx.doi.org/10.3390/ijms150915767
   PubMed Web of Science ®Google Scholar
• Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg 2011; 253:890-9; PMID:21394013; http://dx.doi.org/10.1097/SLA.0b013e3182128929
   PubMed Web of Science ®Google Scholar
• van Rossen ME, Sluiter W, Bonthuis F, Jeekel H, Marquet RL, van Eijck CH. Scavenging of reactive oxygen species leads to diminished peritoneal tumor recurrence. Cancer Res 2000; 60:5625-9; PMID:11059751
   PubMed Web of Science ®Google Scholar
• O'Leary DP, Wang JH, Cotter TG, Redmond HP. Less stress, more success? Oncological implications of surgery-induced oxidative stress. Gut 2013; 62:461-70; PMID:22147551; http://dx.doi.org/10.1136/gutjnl-2011-300948
   PubMed Web of Science ®Google Scholar
• Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000; 88:1739-57; PMID:10738234; http://dx.doi.org/10.1002/(SICI)1097-0142(20000401)88:7%3c1739::AID-CNCR30%3e3.0.CO;2-T
   PubMed Web of Science ®Google Scholar